Prevalence and Significance of Autoantibodies in Children With Acute Liver Failure

Michael R Narkewicz1, Simon Horslen, Steven H Belle

  • 1*Department of Pediatrics, Section of Pediatric Gastroenterology, Hepatology and Nutrition, University of Colorado School of Medicine and Children's Hospital Colorado, Aurora, CO †Division of Gastroenterology and Hepatology, Seattle Children's Hospital ‡Department of Pediatrics, University of Washington School of Medicine, Seattle, WA §Department of Epidemiology ||Department of Biostatistics, University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA ¶Department of Pediatrics #Department of Developmental Biology, Washington University School of Medicine, St. Louis, MO **Division of Pediatric Gastroenterology, Hepatology/Nutrition and Transplant and Regenerative Medicine Centre, The Hospital for Sick Children ††Department of Pediatrics, University of Toronto, Toronto, Canada ‡‡Division of Pediatric Gastroenterology, Hepatology and Nutrition, UCSF Benioff Children's Hospital §§Department of Pediatrics and Surgery, University of California, San Francisco ||||Department of Pediatrics, Division of Pediatric Gastroenterology, Hepatology and Nutrition, Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, GA ¶¶Division of Gastroenterology, Hepatology and Nutrition, The Children's Hospital of Philadelphia ##Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia ***Department of Pediatrics, University of Pittsburgh School of Medicine †††Division of Gastroenterology, Hepatology and Nutrition, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA.

Insights

Autoantibodies are common in pediatric acute liver failure, found in 28% of patients. While positivity doesn't alter outcomes, liver-kidney microsomal (LKM) antibody-positive children are younger and need more transplants.

Area of Science:

  • Pediatric Hepatology
  • Autoimmune Diseases
  • Clinical Immunology

Background:

  • Autoantibodies (auto-ABs) are implicated in various autoimmune conditions.
  • Their role in pediatric acute liver failure (PALF) requires further elucidation.
  • Understanding auto-AB frequency and clinical associations is crucial for diagnosis and management.

Purpose of the Study:

  • To determine the frequency of autoantibodies (antinuclear, smooth muscle, LKM) in children with acute liver failure.
  • To analyze the clinical characteristics and 21-day outcomes of these patients based on auto-AB status.
  • To investigate the association of auto-ABs with specific diagnoses and treatment responses.

Main Methods:

  • Retrospective analysis of 986 participants in the Pediatric Acute Liver Failure Study Group (PALFSG) from 1999-2010.
  • Autoantibody testing performed at local and/or central laboratories.
  • Subjects categorized into autoimmune hepatitis (AIH), indeterminate, and other diagnosis groups based on auto-AB results.

Main Results:

  • Of 722 subjects with available auto-AB results, 202 (28.0%) were positive.
  • Auto-ABs were more frequent in Wilson disease (37.5%) than other diagnoses (20.6%, P=0.03).
  • Liver-kidney microsomal (LKM)+ subjects were younger (median 2.4 vs 9.1 years) and more likely to receive liver transplants (53.3% vs 31.4%).

Conclusions:

  • Autoantibodies are prevalent in pediatric acute liver failure, present in 28% of cases.
  • Auto-AB positivity did not significantly impact 21-day outcomes compared to auto-AB negative subjects.
  • LKM+ children represent a distinct subgroup requiring further investigation due to unique clinical features and higher transplant rates.
Abstract

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
248
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
1.7K
Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
2.1K